+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mannkind Corporation - logo

MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.

Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030 - Product Thumbnail Image

Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030

  • Report
  • October 2024
  • 182 Pages
  • Global
From
Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Human Insulin Drugs Market in Brazil 2024-2028 - Product Thumbnail Image

Human Insulin Drugs Market in Brazil 2024-2028

  • Report
  • December 2023
  • 142 Pages
  • Brazil
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 135 Pages
  • Global
From
Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 133 Pages
  • Global
From
Next Generation Diabetes Therapy and Drug Delivery Market By Product, By Demographic, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030 - Product Thumbnail Image

Next Generation Diabetes Therapy and Drug Delivery Market By Product, By Demographic, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • Report
  • March 2022
  • 254 Pages
  • Global
From
United States Insulin Delivery Devices Market Size, Analysis, Insights, Trends, Share Outlook, Opportunities, Companies and Forecasts up to 2027 - Product Thumbnail Image

United States Insulin Delivery Devices Market Size, Analysis, Insights, Trends, Share Outlook, Opportunities, Companies and Forecasts up to 2027

  • Report
  • October 2021
  • 180 Pages
  • United States
From
Human Insulin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Human Insulin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 144 Pages
  • Global
From
Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • September 2024
  • 135 Pages
  • Global
From
TYVASO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TYVASO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Insulin Delivery Devices Market Outlook, 2028 - Product Thumbnail Image

Insulin Delivery Devices Market Outlook, 2028

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • October 2024
  • 216 Pages
  • Global
From
Diabetic Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Diabetic Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 93 Pages
  • Global
From
Rapid-acting Insulin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Rapid-acting Insulin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
Oral Antidiabetic Oad Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Oral Antidiabetic Oad Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 108 Pages
  • Global
From
Insulin Delivery System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Insulin Delivery System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 123 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Inhalable Drugs Market Size, Share & Trends Analysis Report By Drug Class (Aerosol, Dry Powder Formulation, Spray), By Application (Respiratory & Non-Respiratory Diseases), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Inhalable Drugs Market Size, Share & Trends Analysis Report By Drug Class (Aerosol, Dry Powder Formulation, Spray), By Application (Respiratory & Non-Respiratory Diseases), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 80 Pages
  • Global
From
Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration, By Type, By Onset Time, By Products, By Region, Forecast & Opportunities, 2025 - Product Thumbnail Image

Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration, By Type, By Onset Time, By Products, By Region, Forecast & Opportunities, 2025

  • Report
  • January 2021
  • Global
From
Loading Indicator